Shenzhen BioX Medical Co., Ltd. (Est. 2017) stands at the forefront of China's medical innovation. Our 9,000sqm facility integrates R&D with high-precision manufacturing, supporting global clinical standards.
As industry leaders, we pivot toward AI-integrated diagnostics. Our roadmap focuses on multi-omics data fusion, high-throughput sequencing optimization, and real-time point-of-care (POC) molecular imaging. We anticipate a shift toward personalized medicine where our systems act as the bridge between raw genomic data and clinical actionability.
Leveraging the "Shenzhen Speed," we operate under Industry 4.0 paradigms. Our digitalized supply chain ensures resilience against global disruptions, maintaining a 99.8% on-time delivery rate while keeping per-unit costs optimized through automated manufacturing precision.
We provide localized regulatory support, ensuring our products meet CE, ISO, and regional health authority standards. From North America to Africa, our technical support teams bridge the cultural and technical gaps in diagnostic deployment.
A: We offer the perfect balance of R&D innovation, cost-efficiency, and rigorous international quality compliance.
A: Yes, we provide end-to-end customization for diagnostic firms globally.
BioX Medical
